Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Autophagic degradation determines the fate of T315I-mutated BCR-ABL protein.

× No keyword cloud information.

15 in total

Review 1. The crosstalk between autophagy and apoptosis: where does this lead?

Authors: Claire Gordy; You-Wen He
Journal: Protein Cell Date: 2012-02-09 Impact factor: 14.870

2. Cell cycle-dependent induction of autophagy, mitophagy and reticulophagy.

Authors: Ezgi Tasdemir; M Chiara Maiuri; Nicolas Tajeddine; Ilio Vitale; Alfredo Criollo; José Miguel Vicencio; John A Hickman; Olivier Geneste; Guido Kroemer
Journal: Cell Cycle Date: 2007-07-02 Impact factor: 4.534

3. Anti-cancer fatty-acid derivative induces autophagic cell death through modulation of PKM isoform expression profile mediated by bcr-abl in chronic myeloid leukemia.

Authors: Haruka Shinohara; Kohei Taniguchi; Minami Kumazaki; Nami Yamada; Yuko Ito; Yoshinori Otsuki; Bunji Uno; Fumihiko Hayakawa; Yosuke Minami; Tomoki Naoe; Yukihiro Akao
Journal: Cancer Lett Date: 2015-01-30 Impact factor: 8.679

4. Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival.

Authors: Mohamed Elgendy; Clare Sheridan; Gabriela Brumatti; Seamus J Martin
Journal: Mol Cell Date: 2011-02-25 Impact factor: 17.970

5. In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents.

Authors: Y Kano; M Akutsu; S Tsunoda; H Mano; Y Sato; Y Honma; Y Furukawa
Journal: Blood Date: 2001-04-01 Impact factor: 22.113

6. Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide.

Authors: Dennis J Goussetis; Elias Gounaris; Edward J Wu; Eliza Vakana; Bhumika Sharma; Matthew Bogyo; Jessica K Altman; Leonidas C Platanias
Journal: Blood Date: 2012-08-16 Impact factor: 22.113

7. In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl-positive cell lines.

Authors: Paul La Rosée; Kara Johnson; Amie S Corbin; Eric P Stoffregen; Erika M Moseson; Stephanie Willis; Michael M Mauro; Junia V Melo; Michael W Deininger; Brian J Druker
Journal: Blood Date: 2003-08-21 Impact factor: 22.113

8. A novel Bcl-XL inhibitor Z36 that induces autophagic cell death in Hela cells.

Authors: Jian Lin; Zhibin Zheng; Yanjun Li; Wenyu Yu; Wu Zhong; Songhai Tian; Fang Zhao; Xiaobai Ren; Junhai Xiao; Nan Wang; Siyang Liu; Lili Wang; Fugeng Sheng; Yingyu Chen; Changwen Jin; Song Li; Bin Xia
Journal: Autophagy Date: 2009-04-16 Impact factor: 16.016

9. Autophagy is essential to suppress cell stress and to allow BCR-Abl-mediated leukemogenesis.

Authors: B J Altman; S R Jacobs; E F Mason; R D Michalek; A N MacIntyre; J L Coloff; O Ilkayeva; W Jia; Y-W He; J C Rathmell
Journal: Oncogene Date: 2010-12-13 Impact factor: 9.867

10. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells.

Authors: Cristian Bellodi; Maria Rosa Lidonnici; Ashley Hamilton; G Vignir Helgason; Angela Rachele Soliera; Mattia Ronchetti; Sara Galavotti; Kenneth W Young; Tommaso Selmi; Rinat Yacobi; Richard A Van Etten; Nick Donato; Ann Hunter; David Dinsdale; Elena Tirrò; Paolo Vigneri; Pierluigi Nicotera; Martin J Dyer; Tessa Holyoake; Paolo Salomoni; Bruno Calabretta
Journal: J Clin Invest Date: 2009-04-13 Impact factor: 14.808

1 in total

1. AMP-activated protein kinase activation primes cytoplasmic translocation and autophagic degradation of the BCR-ABL protein in CML cells.

Authors: Daisuke Koyama; Jiro Kikuchi; Yoshiaki Kuroda; Masatsugu Ohta; Yusuke Furukawa
Journal: Cancer Sci Date: 2020-11-16 Impact factor: 6.518

1 in total